Bonevia
Bonevia
High-precision orthopedic systems manufactured to the world's most rigorous medical device standards.
An authoritative analysis of graft fixation performance, metallurgy requirements, and arthroscopic surgical precision.
In reconstructive sports medicine, particularly ligament reconstructions such as the Anterior Cruciate Ligament (ACL) and Posterior Cruciate Ligament (PCL), the selection of fixation devices determines the timeline of structural recovery and joint stability. Titanium interference screws represent the gold standard for securing bone-patellar tendon-bone (BTB) and soft-tissue autografts/allografts within bone tunnels. The mechanical requirements of interference screw fixation demand an optimal balance of structural rigidity, thread sharpness to minimize graft laceration, and a bio-inert surface chemistry that encourages immediate bone contact.
High-end interference screws are manufactured from Titanium-6Aluminum-4Vanadium Extra Low Interstitial (Ti-6Al-4V ELI), corresponding to ASTM F136 specifications. This medical-grade alloy features minimized levels of oxygen, nitrogen, carbon, and hydrogen, which significantly improves fracture toughness and fatigue resistance compared to standard Grade 5 titanium. Biocompatibility is reinforced by the spontaneous formation of a passive titanium dioxide (TiO₂) oxide layer that blocks corrosion and prevents the release of metallic ions into surrounding synovial fluid.
A critical engineering compromise in interference screw manufacturing is the geometry of the screw thread. The threads must be sharp enough to engage bone and graft tissue securely, yet sufficiently rounded to avoid cutting or damaging the delicate collagen fibers of soft-tissue grafts. Progressive thread depth and variable pitch designs allow surgeons to achieve high insertion torque and exceptional pull-out strength without compromising graft integrity. Cannulated designs are mandatory to allow guide wires to direct precise trajectory along the anatomical bone tunnel axis.
Bonevia Orthopedic Technology Co., Ltd. — Setting global benchmarks in orthopedic implant manufacturing.
Bonevia Orthopedic Technology Co., Ltd. is a professional manufacturer specializing in orthopedic implants and surgical solutions, dedicated to advancing innovation in trauma, spine, and joint reconstruction products. Since its establishment in 2015, the company has grown steadily into a trusted supplier in the global orthopedic industry.
With a modern production facility covering approximately 320㎡ (comprising high-precision micro-machining and certified clean packaging spaces), Bonevia maintains strict quality management standards and efficient manufacturing processes. The company records an annual export revenue of around USD 8–15 million, supported by 6 years of export experience and over 10 years of overall industry experience.
Quality assurance is a core focus at Bonevia. The company implements multiple inspection methods including incoming material inspection, in-process quality control, and final product testing, supported by a dedicated quality team of 35 professionals. This ensures all products meet international medical device standards.
Bonevia has a solid trade foundation with diversified global distribution networks, serving major markets across Europe, Southeast Asia, the Middle East, and South America. Its supply chain ecosystem includes more than 850 partners, enabling stable raw material sourcing and efficient production delivery. The company serves a wide range of clients, including hospitals, orthopedic clinics, surgical centers, and medical distributors. Bonevia also demonstrates strong R&D capabilities, offering OEM and ODM customization services to meet specific clinical requirements. In the past year, Bonevia successfully launched 120 new product designs, supported by a research and development team of 85 engineers, continuously driving innovation in orthopedic implant systems and surgical instruments.
Inside Bonevia's advanced fabrication pipeline, from raw material validation to final sterile packaging.
Innovation vectors in next-generation sports medicine fixation devices.
The orthopedic implant sector is transitioning toward biologically active materials and smart geometries. Over the next five years, the research and development roadmap for interference screws centers on three primary technological advancements:
| Feature / Metric | Traditional Machined Titanium | Nanotextured Titanium (TiO₂) | Magnesium Alloy (Absorbable) |
|---|---|---|---|
| Primary Mechanical Fixation | Excellent (> 500 N pull-out) | Excellent (> 520 N pull-out) | Good (~ 400 N pull-out) |
| Osseointegration Rate | Moderate (Contact Osteogenesis) | Fast (Active Osteoblast Recruitment) | Progressive (Simultaneous Bone Replacement) |
| Secondary Removal Requirement | Extremely Rare | Extremely Rare | None (Completely absorbed in 12–18 months) |
| Imaging Interference (MRI/CT) | High Artifact Profile | High Artifact Profile | Negligible Artifact Profile |
Leveraging domestic raw materials, automated robotics, and lean manufacturing cycles to optimize B2B procurement costs.
In global medical device procurement, maintaining supply chain security is crucial for maintaining margins and ensuring clinical access. Bonevia Orthopedic Technology leverages China's industrial ecosystem to deliver reliable medical components.
Our production advantage is driven by three main operational parameters:
A guide for compliance officers, supply chain directors, and clinical engineers.
Procuring implants like titanium interference screws requires strict regulatory verification. B2B procurement managers should evaluate the following structural credentials during factory audits:
Suppliers must hold active ISO 13485 (Medical Devices Quality Management Systems) certifications. Implantable devices must meet CE mark requirements for Europe and applicable FDA clearances for US markets. Cleanrooms must adhere to Class 10,000 (ISO Class 7) standards to prevent particulate and endotoxin contamination prior to sterilization.
Every design batch must be backed by technical documentation demonstrating compliance with:
B2B procurement teams must audit a manufacturer's Statistical Process Control (SPC) records. Every production lot should be traceable to its original raw material heat number. An audit must confirm the separation of raw materials, machined implants, and post-processed, cleanroom-packed final products.
Empowering global medical brands with customized orthopedic implant designs.
Bonevia Orthopedic Technology provides comprehensive OEM and ODM support for orthopedic device companies, surgical instrument brands, and large-scale hospital networks.
Assisting partners with national registrations, regional clinical trials, and customs clearance.
Registering medical devices with regional health authorities (such as ANVISA, HSA, SFDA, or national Ministries of Health) can be a complex process. Bonevia supports global distributors by providing necessary technical documentation, including:
We work with international logistics providers to ensure all shipments are documented correctly with medical-grade HS codes, preventing customs delays at destinations in South America, the Middle East, Southeast Asia, and Europe.
Direct answers from our engineering and metallurgy departments.
Supporting trauma, spine, joint, and veterinary surgical procedures with precision-engineered products.
